By Lynda Williams, medwireNews Reporter
medwireNews: Use of targeted cancer therapies is associated with a clinically relevant increase in the risk of arterial and venous thromboembolic events, indicate findings from a population-based cohort study.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Read the full story on the L’Institut Servier website
Image credit: © vartox / Generated with AI / Stock.adobe.com
